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Summary
African swine fever (ASF) has persisted in Eastern Europe since 2007, and two
endemic zones have been identified in the central and southern parts of the Rus-
sian Federation. Moderate- to low-virulent ASF virus isolates are known to circu-
late in endemic ASF-affected regions. To improve our knowledge of virus
transmission in animals recovered from ASF virus infection, an experimental
in vivo study was carried out. Four domestic pigs were inoculated with the NH/
P68 ASF virus, previously characterized to develop a chronic form of ASF. Two
additional in-contact pigs were introduced at 72 days post-inoculation (dpi) in
the same box for virus exposure. The inoculated pigs developed a mild form of
the disease, and the virus was isolated from tissues in the inoculated pigs up to
99 dpi (pigs were euthanized at 36, 65, 99 and 134 dpi). In-contact pigs showed
mild or no clinical signs, but did become seropositive, and a transient viraemia
was detected at 28 days post-exposure (dpe), thereby confirming late virus trans-
mission from the inoculated pigs. Virus transmission to in-contact pigs occurred
at four weeks post-exposure, over three months after the primary infection. These
results highlight the potential role of survivor pigs in disease maintenance and
dissemination in areas where moderate- to low-virulent viruses may be circulating
undetected. This study will help design better and more effective control pro-
grammes to fight against this disease.
Introduction
African swine fever (ASF) is a highly significant haemor-
rhagic viral disease that has serious sanitary and economic
consequences due to associated high mortality rates and the
international trade restrictions imposed after outbreaks.
ASF affects only porcine species (both wild and domestic)
of all breeds and ages, giving rise to a variety of clinical
signs and lesions (Hess, 1981; Penrith and Vosloo, 2009a;
Penrith, 2009b; Gomez-Villamandos et al., 2013; Sanchez-
Vizcaıno et al., 2015). It is caused by a large complex DNA
virus (ASFV) belonging to the Asfarviridae family for which
no treatment or vaccine is currently available. Therefore,
early detection is crucial in control and eradication strate-
gies.
ASF epidemiology is very complex due to virus and host
characteristics, as well as to the presence of reservoirs. The
disease was first described in 1921 in Kenya and was con-
fined to sub-Saharan Africa until 1957, when it was
detected for the first time outside Africa, in Europe (Lis-
bon, Portugal). It soon spread to other European and
American countries, from where the disease was success-
fully eradicated in most cases. Today, ASF is known to be
endemic in sub-Saharan Africa and in Sardinia (Italy)
(Costard et al., 2009; Arias and Sanchez-Vizcaıno, 2012;
Sanchez-Vizcaıno et al., 2012; Penrith et al., 2013). In
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2007, ASF was introduced into Georgia from East Africa
and spread rapidly to Armenia, Azerbaijan and the Russian
Federation (Rowlands et al., 2008; Food and Agriculture
Organization, United Nations, 2013). The ongoing spread
of ASF into the Ukraine (2012, 2014) and Belarus (2013),
as well as into Russia affecting both wild boar and domestic
pigs, placed neighbouring areas at risk. In early 2014, four
European Union (EU) countries (Lithuania, Poland, Latvia
and Estonia) were also affected, probably as a result of virus
introductions by infected animals from neighbouring
countries to the east along ecological wild boar corridors
(Gallardo et al., 2014). Currently, the disease is threatening
other regions in Europe and Asia due to the potential per-
sistent spillover of the virus into adjacent areas.
ASFV strains are classified as highly, moderately or low
virulent (Pan and Hess, 1984; Blome et al., 2013; Gomez-
Villamandos et al., 2013; Sanchez-Vizcaıno et al., 2015).
Highly virulent strains are usually responsible for the pera-
cute and acute forms that give rise to high mortality rates
that may reach 100% within 4–9 days post-infection. In
peracute ASF, affected animals can die suddenly 1–4 days
after the onset of clinical signs with no evident lesions in
organs. Pigs showing the acute forms of the disease display
mainly a febrile syndrome with erythema and cyanosis of
the skin. Internal lesions are mainly characterized by hyper-
aemic splenomegaly and haemorrhages in organs, particu-
larly in the visceral lymph nodes, with fluids in body
cavities and fibrin strands on organ surfaces. The distribu-
tion and frequency of these lesions are variable, and most
are seen in other swine diseases such as classical swine fever
(CSF). Moderately virulent viruses lead to the appearance
of acute and subacute forms. Pigs with subacute infection
may have persistent or fluctuating temperature responses
for up to 20 days, during which time some pigs stay in
good condition, while others display the symptoms
described above for the acute process form (but less
severely) with mortality rates in the range 30–70%, usually
after 20 dpi. In the chronic form of ASF, clinical signs and
lesions are not specific and may persist for several months,
giving rise to a range of illnesses, with symptoms such as
skin ulcers and arthritis, stunted delayed growth, emacia-
tion, lameness, pneumonia and abortion, but with low
mortality rates. This form was described in the Iberian
Peninsula and in the Dominican Republic in pigs affected
by low-virulent viruses. It has been hypothesized that the
chronic form may be the result of the natural attenuation
of ASFV in the field or may have originated from the exper-
imental vaccine virus released in Iberian Peninsula in the
1960s (Manso Ribeiro et al., 1963; Moulton and Coggins,
1968; Mebus et al., 1978; Mebus and Dardiri, 1979,
1980; Sanchez-Botija, 1982; Pan and Hess, 1984; Leitao
et al., 2001; Sanchez-Vizcaıno et al., 2015; Portugal et al.,
2015).
The in vivo experimental studies using ASFV isolates
affecting Eastern European countries reveal the existence of
virulent strains that induce acute forms of ASF provoking
high mortality in both domestic and wild animals (Gabriel
et al., 2011; Guinat et al., 2014; Gallardo et al., 2015;
Pietschmann et al., 2015). However, since the introduction
of the virus into the Russian Federation in 2007, ASF has
become a large-scale epidemic involving both domestic pig
and wild boar populations, with two recognized endemic
zones in central and southern parts of the Russian Federa-
tion (Gogin et al., 2013). Once the disease is established as
endemic in an area, a broad range of clinical symptoms and
clinical onsets can be expected, although animals that sur-
vive for over a month are able to recover from the infection
and even remain subclinically infected (Mebus et al., 1978;
Mebus and Dardiri, 1979, 1980; Sanchez-Botija, 1982;
Bech-Nielsen et al., 1995; Perez et al., 1998; Arias and San-
chez-Vizcaino, 2002; Arias and Sanchez-Vizcaıno, 2012).
Although in past decades several in vivo experiments
were performed to evaluate the role of survivor animals in
the maintenance of the disease, to date this fact is still
unclear (Wardley et al., 1983; Ordas et al., 1983; Penrith
et al., 2013). The current ASF situation in the Russian Fed-
eration and the series of reported cases within the Eastern
Europe highlight the need to study survivor pigs and their
role in the transmission and maintenance of the virus in
pig populations. Therefore, an experimental in vivo trans-
mission study was performed using the ASFV NH/P68
strain, a low-virulent and non-haemadsorbing isolate that
induces a chronic form of ASF (Leitao et al., 2001). Low-
virulent ASF viruses provide useful models with high sur-
vival rates and thus are appropriate for assessing virus shed-
ding, release and transmission. The results obtained
demonstrated that the animals that recovered were still able
to transmit the virus to a naive population three months
after being infected and so may play a role in the spreading
of the disease.
Methods
Cells and viruses
The NH/P68 isolate (NHV) is a non-haemadsorbing and
low-virulent ASFV isolated from a pig chronically infected
during the ASF epidemic in Portugal in 1968 that took
place eight years after the disease’s first appearance in that
country (Leitao et al., 2001). The virus was propagated and
titrated in primary swine macrophage cultures (Carrascosa
et al., 2011). The ASFV BA71V, isolated in Spain in 1971
and adapted to Vero cells (ATCC CCL 81), was used for
the production of the infected cell cultures for the micro-
plates needed to perform the indirect immunoperoxidase
test (IPT) (Gallardo et al., 2012; European Union Refer-
ence Laboratory (EURL) for African swine fever, 2014).
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The MS stable monkey kidney cell line (ECACC, 91070510)
was used for conventional soluble cytoplasmic antigen pro-
duction after the infection with the ASFV MS-adapted E70
isolate (E70 MS 48), as described in the OIE Manual of
diagnosis (World Organisation for Animal Health (OIE),
2014b).
Experimental design and sampling collection
In vivo experiments were conducted in the BSL3 animal
facilities at CISA-INIA in accordance with Spanish and
European regulations and EC Directive 86/609/EEC, and
following the recommendation 2007/526/EC for the
accommodation and care of animals used for experimental
and other scientific purposes. Four hybrid pigs (named C1
to C4) were inoculated intramuscularly with 105 50% tissue
culture infectious doses per ml (TCID50/ml) of the NHV.
At 72 days post-inoculation (dpi), two additional pigs
(CC13 and CC14) were introduced into the same box as
in-contact (exposed) pigs. The severity of the disease was
expressed using a clinical score, obtained by summing the
score of seven clinical signs recorded on a daily basis
(Table 1). For antibody kinetics and viraemia studies,
paired EDTA blood and sera samples were collected from
pigs at 0, 4, 8, 11, 14, 18, 21, 30, 37, 44, 52, 58, 65, 72, 79,
86, 93, 100, 107, 114, 121, 128 and 134 dpi. The virus was
found to be present in 19 tissue samples (liver, spleen, ton-
sil, heart, lung, kidney, intra-articular tissues of joints and
submandibular, retropharyngeal, inguinal, popliteal,
mesenteric, mediastinal, gastro-hepatic, splenic and renal
lymph nodes) obtained from the inoculated animals, which
were euthanized, respectively, at 35 (C1), 65 (C4), 99 (C3)
and 134 (C2) dpi, and from the in-contact pigs, euthanized
at 42 (CC14) and 62 (CC13) days post-exposure (dpe) (114
and 134 dpi, respectively).
Sample analysis
DNA was extracted from all organ homogenates and blood
samples using the High Pure PCR Template Preparation kit
(Roche) and amplified using OIE conventional (Ag€uero
et al., 2003; World Organisation for Animal Health (OIE),
2014b) and real-time PCR (King et al., 2003; World Organ-
isation for Animal Health (OIE), 2014b). Samples with
recorded threshold cycle number (Ct) < 40.0 were consid-
ered positive and samples with no recorded Ct value were
considered negative (World Organisation for Animal
Health (OIE), 2014b). Virus isolation and titration were
performed using porcine peripheral blood macrophages
(PBM) (Carrascosa et al., 2011). Detection of ASFV-speci-
fic antibodies was performed in serum using the commer-
cial ELISA (INGENASA-INGEZIM PPA COMPAC K3
INGENASA, Madrid, Spain), the OIE-Indirect ELISA
(World Organisation for Animal Health (OIE), 2014b),
and the IPT validated by the EURL (Gallardo et al., 2012;
European Union Reference Laboratory (EURL) for African
swine fever, 2014).
Results
Inoculated animals
Clinical findings and gross lesions
The inoculated animals developed variable clinical manifes-
tations ranging from subclinical infection (C2) to clinical
signs of different intensity – more intense in C1 than in C3
followed by C4 – associated with a chronic form of ASF ini-
tiated at 14  3 dpi (Fig. 1a). The predominant clinical
symptoms were (i) recurrent transient fever, mainly in pigs
C1 and C4 (Fig. 1b), (ii) joint swelling (moderate to severe)
with reddened areas of skin that became raised and necrotic
(Fig. 2a), (iii) gradual weight loss and (iv) respiratory dis-
tress with spasmodic coughing over the period of a month,
most evident in C3. Animals were slaughtered at 35 (C1),
65 (C4), 99 (C3) and 134 (C2) dpi to determine the pres-
ence of ASFV in tissues. Macroscopic lesions found during
necropsies performed at 35 and 65 dpi included fibrinous
Table 1. List of clinical signs used to create the ASF clinical score
1. Anorexia 0. no abnormality
1. Mild (reduced eating)
2. Moderate (only picking at food)
3. Severe (not eating)
2. Recumbence 0. no abnormality
1. Mild (stillness)
2. Moderate (get up only when touched)
3. Severe (remain recumbent when touched)
3. Skin Haemorrhage/
Cyanosis
0.no abnormality
1. Mild
2. Moderate
3. Severe
4. Swelling 0. no abnormality
1. Mild (joint swelling)
2. Moderate (lameness, necrotic foci)
3. Severe (severe lameness, impaired
walking)
5. Laboured breathing
and/or coughing
0. no abnormality
1. Mild
2. Moderate
3. Severe
6. Ocular discharge 0. no abnormality
1. Mild
2. Moderate
3. Severe
7. Digestive findings 0. no abnormality
1. Mild (normal diarrhoea<24 h)
2. Moderate (diarrhoea, vomiting>24 h)
3. Severe (bloody diarrhoea)
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pericarditis and oedematous and partially haemorrhagic
lymph nodes, mainly gastro-hepatic, renal and mediastinal.
The pig slaughtered at 99 dpi (C3) had severe pneumonia
with caseous lobular consolidation and calcification of
areas of the lungs (Fig. 2b) and focal lesions in the thoracic
lymph nodes. No significant lesions were found in the
asymptomatic animal (C2) slaughtered at 134 dpi.
Viremia, humoral response and ASFV distribution in tissues
Viremia was detected to a variable extent in the inoculated
pigs (Fig. 3a). In pig C1, which developed a more intense
chronic form of infection, viremia was detected at 18 dpi
and remained positive until slaughtered at 35 dpi. Infec-
tious viruses were recovered from all positive blood sam-
ples including the PCR-positive blood samples obtained
from pig C4 at 21, 58, 62 and 65 dpi. Interestingly, despite
having similar Ct values, no infectious virus was recovered
from pig C3, which developed a viremia that lasted for over
two months (14–99 dpi). The subclinical infected pig C2
was aviraemic on all analysis days. Anti-ASFV-specific anti-
bodies were detected at 8 dpi in all pigs using IPT and at 8–
14 dpi (depending on the animal) by the ELISA tests. The
anti-ASFV antibody titre was quite low in the asymp-
tomatic animal, whereas symptomatic animals yielded very
high values (>105) until the end of the experiment
(Fig. 3b).
The ASFV genome was detected by PCR in all tissue sam-
ples obtained from the two inoculated animals slaughtered
at 35 and 65 dpi. After three passages in PBM cells, the
ASFV was recovered from 16 (84.21%) and 12 (63.15%)
different tissue samples. In the animal euthanized at 99 dpi,
the virus genome was detected in 12 of the 19 (63.1%)
collected tissues, although virus could only be recovered
from the lung and mediastinal lymph node. However, these
samples yielded high titre values (>107TCDI50/ml). No
positive ASFV result was obtained from samples collected
from the inoculated animal slaughtered at 134 dpi (C2).
The results are summarized in Table 2.
In-contact animals
Clinical findings and gross lesions
At 72 dpi, two in-contact pigs (CC13 and CC14) were
introduced into the same box as the inoculated animals C2
and C3. At the time of exposure, both inoculated animals
had high antibody titre levels and one (C3) had a weak vir-
emia (Fig. 3a,b). In one of the in-contact pigs (CC14), the
clinical signs relating to a chronic form of ASF began at 30–
Fig. 1. Clinical score (a) and temperature (b) in the NHV ASFV-inoculated (in grey) and in-contact (in red) groups.
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32 dpe and resembled those observed in the inoculated ani-
mals, which is, mainly joint swelling, temperature above
40°C, and respiratory disorders (Fig. 1a,b). The second in-
contact pig (CC13) did not develop any detectable clinical
signs other than a weak peak of fever over 40°C at 45 dpe
(Fig. 1b). The in-contact pigs were euthanized at 42 dpe
(CC14) and 62 dpe (CC13) to assess lesions and virus pres-
ence in tissues. The post-mortem examination revealed
macroscopic lesions including caseous necrosis and focal
mineralization of the lungs, fibrin deposits in tracheal
lumen, and oedematous and partially hyperaemic bronchial
lymph nodes. Theses lesions were more intense in pig
CC14 slaughtered at 42 dpe than in pig CC13 (Fig. 2c).
Viremia, humoral response and ASFV distribution in tissues
The first viraemia peak was identified in pig CC14 at 28
dpe, prior to the appearance of clinical signs, whereas in
pig CC13 two peaks of viraemia were detected at 49 and 56
dpe (Fig. 3a). Antibodies were found in both animals from
35 dpe to the end of the experiment (Fig. 3b). The presence
of ASFV was demonstrated by PCR in all tested tissues in
the animal slaughtered at 42 dpe, with titres in the range
106.3–108.3 TCID50/ml. In the exposed pig CC13 (62 dpe),
a positive PCR result was obtained in 10 of 19 (52.5%) tis-
sues samples, although no virus could be recovered after
three passages in primary cultures (Table 2).
Discussion
When introduced into a region or a domestic pig popula-
tion, ASF is typically associated with high mortality rates
and a rapid spread of outbreaks (Costard et al., 2009;
Sanchez-Vizcaıno et al., 2012). However, several studies
have demonstrated that in areas where ASF becomes ende-
mic, increased numbers of subacute, chronic and subclini-
cal infections also occur, and that mortality rates decline
over time. In such situations, the clinical manifestations of
this disease are more variable and difficult to recognize in
the field. The infection can persist for several months with
no particular obvious symptoms in the infected animals,
other than stunting or emaciation, or may even mimic cer-
tain other illnesses (Mebus et al., 1978; Mebus and Dardiri,
1979, 1980; Thomson et al., 1979; Hess, 1981; Wilkinson
et al., 1981, 1983; Wilkinson, 1984; Sanchez-Botija, 1982;
Nsalambi, 1993; Boinas et al., 2004; Penrith et al., 2013;
Sanchez-Vizcaıno et al., 2015).
Although no long-term carrier state has yet been experi-
mentally demonstrated, subclinically infected, chronically
infected or survivor pigs are likely to play an important role
in the epidemiology of the disease, that is in disease persis-
tence in endemic areas or in sporadic outbreaks or ASF
introduction into free zones (Allaway et al., 1995; Arias
and Sanchez-Vizcaino, 2002; Arias and Sanchez-Vizcaıno,
2012; Penrith and Vosloo, 2009a; Penrith, 2009b; Costard
et al., 2009). Field studies in affected regions such as Brazil
and the Iberian Peninsula (1979–1981) have revealed that
3.5% and 0.6% of new outbreaks, respectively, are thought
to be caused by seropositive domestic pigs that had recov-
ered from an initial infection (Sanchez-Botija, 1982; Vig-
ario et al., 1983; Ordas et al., 1983; Bech-Nielsen et al.,
1995). The presence of subclinical and chronic forms in
endemic regions could be related to the acquired immunity
(a)
(c)
(b)
Fig. 2. (a) Necrotic area and joint swelling of
left metatarsus; C1, slaughtered at 35 dpi. (b)
Severe bilateral caseous pneumonia; mediasti-
nal lymph nodes appear enlarged; C3, slaugh-
tered at 99 dpi. (c) Consolidation areas (darker)
and caseous lobular pneumonia; a slight opac-
ity of pleura can also be noted; CC14, slaugh-
tered at 42 dpe.
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from previous exposure to lower doses of virus and/or the
presence of related viruses of reduced virulent that may
have emerged after many years of circulation in domestic
pig populations. In the Iberian Peninsula, the release in the
field of more than 400 000 doses of vaccine based on atten-
uated ASFV resulted in viruses of lower pathogenicity
which gave rise to atypical form of the disease (Penrith
et al., 2004; Penrith and Vosloo, 2009a; Penrith, 2009b;
Sanchez-Vizcaıno et al., 2015; Portugal et al., 2015).
Despite field evidence, the exact role of seropositive sur-
vivor animals in the maintenance of ASFV among pig pop-
ulations is still unclear. In this study, a formal procedure to
assess the capacity of ASFV-infected survivor pigs to trans-
mit the virus after 72 days of primary infection was carried
out. In addition, the presence of the virus in tissue samples
over time was evaluated by a regular follow-up of clinical
infection, bleeding and euthanasia at different times post-
infection. Different parameters such as viraemia and
humoral response, as well as pathological findings, were
analysed in experimentally infected and exposed pigs. In
agreement with the previous findings (Leitao et al., 2001),
three of the four experimentally NHV-inoculated pigs
developed a chronic form of ASF to variable degrees of
intensity with common features such as swelling above leg
joints, necrotic foci in the skin and clinical respiratory
symptoms. Animals had recurring cycles of pyrexia and vir-
emia and the virus was isolated from the blood during peri-
ods of high temperature for at least 65 dpi (C4), even
though the cycle threshold (Ct) values were >30. Lesions
revealed at necropsy mainly consisted of chronic fibrinous
pericarditis and caseous necrosis, and the calcification of
the lungs, related to the presence of pneumonia. Such res-
piratory symptoms and lesions associated with chronic
forms of ASF have been often recognized as a consequence
of bacterial secondary infections (Coggins and Colgrove,
1968; Moulton and Coggins, 1968; Moulton et al., 1975;
Pan et al., 1975). An analysis of virus replication in the tis-
sues of pigs slaughtered between 35 and 134 dpi showed
Fig. 3. Viremia (a) and anti-ASFV antibody titre measured using the OIE real-time PCR and the IPT, respectively, in the group of the inoculated (grey
lines) and in-contact pigs (red lines) introduced at 72 dpi. The days post-exposure are indicated in brackets.
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evidence of virus at up to 99 dpi in lung and thoracic
lymph nodes at levels that were sufficient to infect naive
pigs (>107TCDI50). The persistence of the virus in organs
such as the respiratory tract implies a risk factor for virus
transmission to other animals, which thus could contribute
to the spread and maintenance of the disease. This finding
has been reported in other experimental studies that have
identified tissues as a source of virus at up to 180 dpi dur-
ing persistent infections with moderately virulent isolates
(Mebus and Dardiri, 1980; Wilkinson et al., 1981; Wilkin-
son, 1984; Hamdy and Dardiri, 1984; Oura et al., 1998).
More recently, certain studies have reported that in suba-
cute infections using ASFV isolates of moderate virulent
(Brazil 1978, Malta 1978 and Netherlands 1986), viraemic
surviving pigs were able to shed virus from their orophar-
ynx for at least 70 days (de Carvalho Ferreira et al., 2012,
2013a,b). In comparison with the animals that succumb to
the disease, it seems clear that pigs that recover may shed
virus for up to a month after the disappearance of clinical
signs. Lower amounts and frequency of shedding were
observed after 30 dpi, although transmission to susceptible
pigs may still be possible, through either direct or indirect
contact (de Carvalho Ferreira et al., 2012).
One inoculated animal (C2) remained asymptomatic
throughout the experimental study, although its antibody
response detected at 8 dpi and maintained until 134 dpi
shows that it was infected with ASFV. The non-appearance
of clinical signs might be linked to low transient levels of
viremia that probably appeared before the collection of the
first blood samples. The absence of ASFV in tissues samples
(taken at 134 dpi) may reflect the existence of low transient
levels of viremia in that particular pig. Lower anti-ASFV-
specific antibody titres were detected in the asymptomatic
animal than in pigs that developed chronic infection. This
agrees with the previous observations (Leitao et al., 2001)
that have identified two clinical groups in pigs infected with
NHV ASFV: (i) pigs developing chronic-type ASF lesions
with viraemia and fever after 14 dpi and high levels of anti-
ASFV-specific antibodies and (ii) pigs remaining asymp-
tomatic that are neither viraemic nor febrile at 14 dpi and
have relatively low levels of anti-virus antibody titres.
By introducing two na€ıve pigs at 72 dpi, we aimed to
determine the ability of chronically ASFV-infected animals
to transmit ASFV to susceptible populations. Despite the
small number of pigs used in the study, the results obtained
show that persistently infected pigs can efficiently transmit
the virus to naive pigs after a period of even four (CC14) or
five (CC13) weeks after the initial exposure, that is over
three months after the virus was first inoculated. In spite of
the fact that at the time of the exposure only one of the pre-
viously inoculated animals had a weak viremia peak (Ct ~
35), the virus was easily transmitted, probably due to the
presence of infectious ASFV in the pigs’ respiratory tracts.
As reported above for the inoculated pigs, one of the in-
contact animals developed a mild course of chronic ASF
and one remained asymptomatic. These mild clinical signs
could easily remain unnoticed under field conditions, and
only laboratory tests, necessary for confirming transient
viremia and the presence of anti-ASFV-specific antibodies
in exposed animals, can make them detectable. These data
support the idea that control–eradication programmes in
areas with a clear endemic status should include parallel
routine laboratory monitoring, together with the regular
clinical inspection of animals by keepers. It is important to
underline that an effective control programme will always
require laboratory monitoring. However, in some endemic
areas of sub-Saharan Africa, governments and farmers
would not be able to afford such intense controls. Never-
theless, the reinforcement of preventive biosecurity mea-
sures to guarantee the safe production and marketing of
pigs and pig products in these regions could be promoted
as a means of optimizing control strategies based on risk
reduction that would lessen the laboratory costs of contin-
gency and control plans.
Summarizing, this work demonstrates that pigs infected
with low-virulent strains of ASFV are able to transmit the
virus within three months of infection and that infectious
virus are retained in tissues for up to 99 dpi. These find-
ings confirm previous experimental studies that report
virus shedding for at least 70 days (de Carvalho Ferreira
et al., 2012; de Carvalho Ferreira et al., 2013a; de Car-
valho Ferreira et al., 2013b) and the persistence of virus in
tissues for up to six months (Wilkinson, 1984; Oura
et al., 2005). By contrast, other studies report that the sur-
vivor pigs experimentally infected with Brazilian and
Dominican Republic isolates excrete the virus intermit-
tently for up to a month and that transmission to contact
animals could only occur during this period. Long-surviv-
ing seropositive animals were not able to transmit the
virus beyond 135 and 110 days to susceptible pigs after a
contact period of 14 days (Wilkinson et al., 1981; Mebus
and Dardiri, 1980). The failure of in-contact pigs to
become infected during different experiments when
exposed might be due to a short exposure period as this
disease is not highly contagious (Wilkinson et al., 1981;
Penrith et al., 2004).
Existent data undoubtedly provide evidence that sur-
vivor animals that have recovered from ASFV infection can
still play a role in virus transmission and dissemination.
We cannot exclude the possibility that this virus may estab-
lish a latent infection in some tissues and, under certain
natural or induced conditions (transport, underfeeding,
immunosuppression, etc.), may be reactivated, thereby
facilitating its transmission. These possibilities are clearly
important and need to be investigated, along with the fate
of the virus in pigs that recover from the disease.
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